Veterinary CRO And CDMO Market Size, Share & Trends Analysis Report By Animal Type (Companion, Livestock), By Service Type (Discovery, Development), By Application, By Region- Global Industry Analysis, Share, Growth, Regional Outlook and Forecasts, 2023-2032

The global veterinary CRO and CDMO market size was exhibited at USD 6.9 billion in 2022 and is projected to hit around USD 16.26 billion by 2032, growing at a CAGR of 8.95% during the forecast period 2023 to 2032.

Key Pointers:

  • North American region dominated the animal health CRO & CDMO market with the largest revenue share of more than 30.19% in 2022.
  • The livestock animal segment dominated the industry in 2022 with a revenue share of 40.8% of the overall revenue.
  • The companion animal segment is expected to grow at the fastest CAGR during the projected period. 
  • The development segment generated the largest revenue share of over 30.25% in 2022 and dominated the global industry. 
  • The medicine segment dominated the market in 2022 and generated the largest revenue share of more than 62.85%. 
  • The medical devices segment, on the other hand, is expected to grow at the fastest CAGR during the projected period.

Veterinary CRO And CDMO Market Report Scop

Report Coverage

Details

Market Size in 2023

USD 7.52 Billion

Market Size by 2032

USD 16.26 Billion

Growth Rate From 2023 to 2032

CAGR of 8.95%

Base Year

2022

Forecast Period

2023 to 2032

Segments Covered

Animal type, Service type, Application

Market Analysis (Terms Used)

Value (US$ Million/Billion) or (Volume/Units)

Regional Scope

North America; Europe; Asia Pacific; Central and South America; the Middle East and Africa

Key Companies Profiled

Labcorp Drug Development; Charles River Laboratories.; Clinvet; KLIFOVET GmbH (Argenta Group); OCR – Oncovet Clinical Research; Knoell – Triveritas; Veterinary Research Management; VETSPIN; Inotiv.; IDEXX Laboratories; Zoetis – Nexvet; Vetio

 

The market is driven by several factors, including the growing number of expert contract research & manufacturing organizations in developing countries, rising adoption of outsourcing services in key stages of veterinary product developments, increasing animal healthcare investments by major players, and growing demand for novel therapeutic products. In addition, the rising adoption of companion animals and growing demand for animal-derived food products are increasing the need for the mass production of medicines.

Therefore, employing the network of third-party Contract Development & Manufacturing Organizations (CDMO) and Contract Research Organizations (CRO) favors the production scale on time with reduced financial risk. The COVID-19 pandemic caused the market downturn, especially during the year 2020. The primary challenges experienced by the majority of contract outsourcing organizations were enormous resource allocation shifts from non-covid to covid medicines (targeting human applications), supply shortages of veterinary raw materials & APIs, transportation & logistics disruption, and the need for more transparency with the vendors. In addition, other difficulties, such as establishing interruption-free, timely, and reliable supply chains, have added more complexity to outsourcing organizations in developing or manufacturing veterinary products.

However, the market growth quickly recovered the following year with significant measures implemented by key players and contract organizations. While it created numerous challenges, the pandemic also set new trends, such as increased ownership rates of companion animals and pet humanization, coupled with improved animal care expenditure and widened R&D activities in the context of global awareness of prognostic and diagnostic measures. According to the American Pet Products Association, pet care expenditure in the U.S. increased from USD 91.5 billion in 2018 to 166.6 billion in 2022. These factors are anticipated to support the employment of contract research, development, and manufacturing organizations by key players in the long run.

Some of the prominent players in the Veterinary CRO And CDMO Market include:

  • Labcorp Drug Development
  • Charles River Laboratories
  • Clinvet
  • KLIFOVET GmbH (Argenta Group)
  • OCR – Oncovet Clinical Research
  • Knoell – Triveritas
  • Veterinary Research Management
  • VETSPIN
  • Inotiv.
  • IDEXX Laboratories
  • Zoetis – Nexvet
  • Vetio

Segments Covered in the Report

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2032. For this study, Nova one advisor, Inc. has segmented the global Veterinary CRO And CDMO market.

By Animal Type 

  • Companion Animals
  • Livestock Animals

By Service Type 

  • Discovery
  • Development
  • Manufacturing
  • Packaging & Labeling
  • Market Approval & Post-marketing
    • Early Phase/Preclinical
    • Late Phase/Clinical

By Application 

  • Medicines
  • Medical Devices
  • Pharmaceuticals
  • Biologics
  • Others

By Region

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East & Africa (MEA)

Frequently Asked Questions

The global veterinary CRO and CDMO market size was exhibited at USD 6.9 billion in 2022 and is projected to hit around USD 16.26 billion by 2032

The global veterinary CRO and CDMO market is expected to grow at a compound annual growth rate (CAGR) of 8.95% from 2023 to 2032

b.Some key players operating in the global veterinary CRO and CDMO market include Labcorp Drug Development; Charles River Laboratories.; clinvet; KLIFOVET GmbH (Argenta Group); OCR – Oncovet Clinical Research; knoell – Triveritas; Veterinary Research Management; VETSPIN; Inotiv.; IDEXX Laboratories; Zoetis – Nexvet, and Vetio.

Chapter 1 Research Methodology & Scope
                   1.1 Market Segmentation & Scope
                       1.1.1 Estimates & Forecast Timeline
                   1.2 Research Methodology
                   1.3 Information Procurement
                       1.3.1 Purchased database
                       1.3.2 Nova one advisor’s Internal Database
                       1.3.3 Secondary sources
                       1.3.4 Primary Research
                       1.3.5 Details of Primary Research
                   1.4 Information or Data Analysis
                       1.4.1 Data Analysis Models
                   1.5 Market Formulation & Validation
                   1.6 Model Details
                       1.6.1 Commodity Flow Analysis
                   1.7 List of Secondary Sources
                   1.8 Objectives
Chapter 2 Executive Summary
                   2.1 Market Snapshot, 2023
                   2.2 Segment Snapshot
                   2.3 Competitive Snapshot
Chapter 3 Veterinary CRO & CDMO Market: Market Variables Trends & Scope
                   3.1 Market Lineage Outlook
                       3.1.1 Parent Market Analysis
                       3.1.2 Ancillary Market Analysis
                   3.2 Market Dynamics
                       3.2.1 Market Driver Analysis
                       3.2.2 Market Restraint Analysis
                   3.3 Industry Analysis
                       3.3.1 Porter’s 5 Forces Analysis
                           3.3.1.1 Bargaining Power Of Buyers
                           3.3.1.2 Bargaining Power Of Suppliers
                           3.3.1.3 Threat Of New Entrants
                           3.3.1.4 Threat Of Substitutes
                           3.3.1.5 Industry Rivalry: High
                       3.3.2 Pestel Analysis
                           3.3.2.1 Political & Legal Landscape
                           3.3.2.2 Economic & Social Landscape
                           3.3.2.3 Environmental Landscape
                           3.3.2.4 Technology Landscape
                   3.4 Estimated Animal Population, 2020 - 2023, by Key Species & Key Countries
                   3.5 Regulatory Framework
                   3.6 Estimated Global Sales by 50 Key Veterinary Medicines, 2020 - 2023
                   3.7 Opportunity Analysis/Unmet Needs
                   3.8 COVID-19 Impact Analysis
Chapter 4 Veterinary CRO & CDMO Market: Animal Type Analysis
                   4.1 Animal Type Market Share Analysis, 2023 & 2032
                   4.2 Veterinary CRO & CDMO Market: Animal Type Movement Analysis, 2020 to 2032
                   4.3 Companion Animals
                       4.3.1 Companion animals market estimates and forecasts, 2020 - 2032
                   4.4 Livestock Animals
                       4.4.1 Livestock animals market estimates and forecasts, 2020 - 2032
Chapter 5 Veterinary CRO & CDMO Market: Service Type Analysis
                   5.1 Service Type Market Share Analysis, 2023 & 2032
                   5.2 Veterinary CRO & CDMO Market: Service Type Movement Analysis, 2020 to 2032
                   5.3 Discovery
                       5.3.1 Discovery market estimates and forecasts, 2020 - 2032
                   5.4 Development
                       5.4.1 Development market estimates and forecasts, 2020 - 2032
                       5.4.2 Early Phase/Preclinical
                           5.4.2.1 Early phase/preclinical market estimates and forecasts, 2020 - 2032
                       5.4.3 Late Phase/Clinical
                           5.4.3.1 Late phase/clinical market estimates and forecasts, 2020 - 2032
                   5.5 Manufacturing
                       5.5.1 Manufacturing market estimates and forecasts, 2020 - 2032
                   5.6 Packaging & Labeling
                       5.6.1 Packaging & labeling market estimates and forecasts, 2020 - 2032
                   5.7 Market Approval & Post-marketing
                       5.7.1 Market approval & post marketing market estimates and forecasts, 2020 - 2032
Chapter 6 Veterinary CRO & CDMO Market: Application Analysis
                   6.1 Application Market Share Analysis, 2023 & 2032
                   6.2 Veterinary CRO & CDMO Market: Application Movement Analysis, 2020 to 2032
                   6.3 Medicines
                       6.3.1 Medicines market estimates and forecasts, 2020 - 2032
                       6.3.2 Pharmaceuticals
                       6.3.2.1 Pharmaceuticals market estimates and forecasts, 2020 - 2032
                       6.3.3 Biologics
                           6.3.3.1 Biologics market estimates and forecasts, 2020 - 2032
                       6.3.4 Others
                           6.3.4.1 Others market estimates and forecasts, 2020 - 2032
                   6.4 Medical Devices
                       6.4.1 Medical devices market estimates and forecasts, 2020 - 2032
Chapter 7 Veterinary CRO & CDMO Market: Regional Market Analysis, 2020 - 2032
                   7.1 Regional Market Share Analysis, 2023 & 2032
                   7.2 Regional Market Snapshot
                   7.3 North America
                       7.3.1 SWOT Analysis:
                           7.3.1.1 North America Veterinary CRO & CDMO market estimates and forecasts, 2020 - 2032
                       7.3.2 U.S.
                           7.3.2.1 Key Country Dynamics
                           7.3.2.2 Competitive Scenario
                           7.3.2.3 U.S. Veterinary CRO & CDMO market estimates and forecasts, 2020 - 2032
                       7.3.3 Canada
                           7.3.3.1 Key Country Dynamics
                           7.3.3.2 Competitive Scenario
                           7.3.3.3 Canada Veterinary CRO & CDMO market estimates and forecasts, 2020 - 2032
                   7.4 Europe
                       7.4.1 SWOT Analysis:
                           7.4.1.1 Europe Veterinary CRO & CDMO market estimates and forecasts, 2020 - 2032
                       7.4.2 U.K.
                           7.4.2.1 Key Country Dynamics
                           7.4.2.2 Competitive Scenario
                           7.4.2.3 U.K. Veterinary CRO & CDMO market estimates and forecasts, 2020 - 2032
                       7.4.3 Germany
                           7.4.3.1 Key Country Dynamics
                           7.4.3.2 Competitive Scenario
                           7.4.3.3 Germany Veterinary CRO & CDMO market estimates and forecasts, 2020 - 2032
                       7.4.4 France
                           7.4.4.1 Key Country Dynamics
                           7.4.4.2 Competitive Scenario
                           7.4.4.3 France Veterinary CRO & CDMO market estimates and forecasts, 2020 - 2032
                       7.4.5 Italy
                           7.4.5.1 Key Country Dynamics
                           7.4.5.2 Competitive Scenario
                           7.4.5.3 Italy Veterinary CRO & CDMO market estimates and forecasts, 2020 - 2032
                       7.4.6 Spain
                           7.4.6.1 Key Country Dynamics
                           7.4.6.2 Competitive Scenario
                           7.4.6.3 Spain Veterinary CRO & CDMO market estimates and forecasts, 2020 - 2032
                   7.5 Asia Pacific
                       7.5.1 SWOT Analysis:
                           7.5.1.1 Asia Pacific Veterinary CRO & CDMO market estimates and forecasts, 2020 - 2032
                       7.5.2 Japan
                           7.5.2.1 Key Country Dynamics
                           7.5.2.2 Competitive Scenario
                           7.5.2.3 Japan Veterinary CRO & CDMO market estimates and forecasts, 2020 - 2032
                       7.5.3 China
                           7.5.3.1 Key Country Dynamics
                           7.5.3.2 Competitive Scenario
                           7.5.3.3 China Veterinary CRO & CDMO market estimates and forecasts, 2020 - 2032
                       7.5.4 India
                           7.5.4.1 Key Country Dynamics
                           7.5.4.2 Competitive Scenario
                           7.5.4.3 India Veterinary CRO & CDMO market estimates and forecasts, 2020 - 2032
                       7.5.5 Australia
                           7.5.5.1 Key Country Dynamics
                           7.5.5.2 Competitive Scenario
                           7.5.5.3 Australia Veterinary CRO & CDMO market estimates and forecasts, 2020 - 2032
                       7.5.6 South Korea
                           7.5.6.1 Key Country Dynamics
                           7.5.6.2 Competitive Scenario
                           7.5.6.3 South Korea Veterinary CRO & CDMO market estimates and forecasts, 2020 - 2032
                   7.6 Latin America
                       7.6.1 SWOT Analysis
                           7.6.1.1 Latin America Veterinary CRO & CDMO market estimates and forecasts, 2020 - 2032
                       7.6.2 Brazil
                           7.6.2.1 Key Country Dynamics
                           7.6.2.2 Competitive Scenario
                           7.6.2.3 Brazil Veterinary CRO & CDMO market estimates and forecasts, 2020 - 2032
                       7.6.3 Mexico
                           7.6.3.1 Key Country Dynamics
                           7.6.3.2 Competitive Scenario
                           7.6.3.3 Mexico Veterinary CRO & CDMO market estimates and forecasts, 2020 - 2032
                   7.7 MEA
                       7.7.1 SWOT Analysis:
                           7.7.1.1 MEA Veterinary CRO & CDMO market estimates and forecasts, 2020 - 2032
                       7.7.2 South Africa
                           7.7.2.1 Key Country Dynamics
                           7.7.2.2 Competitive Scenario
                           7.7.2.3 South Africa Veterinary CRO & CDMO market estimates and forecasts, 2020 - 2032
                       7.7.3 Saudi Arabia
                           7.7.3.1 Key Country Dynamics
                           7.7.3.2 Competitive Scenario
                           7.7.3.3 Saudi Arabia Veterinary CRO & CDMO market estimates and forecasts, 2020 - 2032
Chapter 9 Veterinary CRO & CDMO Market - Competitive Landscape
                   9.1. Labcorp Drug Development
                   9.2. Charles River Laboratories
                   9.3. clinvet
                   9.4. KLIFOVET GmbH (Argenta Group)
                   9.5. OCR - Oncovet Clinical Research
                   9.6. knoell - Triveritas
                   9.7. Veterinary Research Management
                   9.8. VETSPIN
                   9.9. Inotiv.
                   9.10. IDEXX Laboratories
                   9.11. Zoetis - Nexvet
                   9.12. Vetio
                   9.13 Participant’s Overview
                   9.14 Financial Performance
                   9.15 Service Benchmarking
                   9.16 Participant Categorization
                   9.17 Strategy Mapping
                   9.18 List of Private Players

Proceed To Buy

USD 4500
USD 3800
USD 1900
USD 1200

Customization Offered

  • check-imgCross-segment Market Size and Analysis for Mentioned Segments
  • check-imgAdditional Company Profiles (Upto 5 With No Cost)
  • check-img Additional Countries (Apart From Mentioned Countries)
  • check-img Country/Region-specific Report
  • check-img Go To Market Strategy
  • check-imgRegion Specific Market Dynamics
  • check-imgRegion Level Market Share
  • check-img Import Export Analysis
  • check-imgProduction Analysis
  • check-imgOthers
Ask To Expert